Job Title Sort ascending Business Location Site Date Posted Equipment Specialist (m/w/d), Kundl, Tirol, Österreich Regulär, Full time Innovative Medicines Austria Kundl Oct 18, 2024 Trainee Marketing ...

V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

Explorați mai jos oportunitățile cu Novartis și Sandoz. Pentru roluri suplimentare cu Novartis Gene Therapies (fost AveXis), vizitați the Căutare de carieră GTx .

Job Title Sort ascending Business Location Site Date Posted Senior Scientist - in-vivo pharmacology/oncology (Radioligand Therapy) (80-100%*) Regular, Full time Pharma Research Switzerland Basel (City ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

חפשו אחר אפשרויות תעסוקה בחברת נוברטיס וסנדוז. לתפקידים נוספים ב Novartis Gene Therapies (formerly AveXis) בקרו בGTx Career Search הודעה למתמודדים על משרות בארה"ב. למדו עוד Customer Service ...

Process Expert (m/f/d) - Temporary Befristet (Befristet), Full time Innovative Medicines Austria Schaftenau nov 08, 2024 Equipment Specialist (m/w/d), Kundl, Tirol, Österreich – Teilzeit 70% Regulär, ...

Sr. Sales Executive-BC Regular (Sales), Full time Innovative Medicines Hong Kong Special Administrative Region, China Hong Kong Nov 07, 2024 ...

Operater v proizvodnji farmacevtskih učinkovin (m/ž/d) Temporary (Fixed Term), Full time Innovative Medicines Slovenia Mengeš Nov 06, 2024 Tehnik v proizvodnji bioloških učinkovin (m/ž/d) Temporary ...

Job Title Sort ascending Business Location Site Date Posted Allergy Territory Account Specialist – Boston North – Remote Regular, Full time Innovative Medicines USA +Alternative Locations Field Sales ...

(高级）医药代表 /（资深）产品专员 Regular (Ventas), Full time Innovative Medicines Cina Shenzhen (Guangdong Province) Nov 04, 2024 (高级 ...

Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...